BreastfeedingTENDERNCT07569172
Improved Child Nutrition and Development Through Social Transfers
A study testing Social Transfer in people with Breastfeeding and Breastfeeding Education, run by Swiss Tropical & Public Health Institute at 1 site in Côte d’Ivoire.
Trial summary
The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. Read more about this study
- Who is it for?
- Ages 12 years and older, women only
- Conditions the study is for
- Breastfeeding, Breastfeeding Education, Breastfeeding Duration
- What is being tested?
- Social Transfer
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,040 participants
- Where
- 1 siteCôte d’Ivoire
- Study dates
- 1 Jun 2026to 28 Feb 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Are enrolled in the Taabo multigenerational birth cohort (MGC)
- Completed the postpartum interview of the Taabo MGC
- Have a child who is within two weeks of their 12-month birthday,
- are breastfeeding at time of recruitment,
- live in the Taabo HDSS, Côte d'Ivoire
- have no illnesses that contraindicates breastfeeding,
- had a healthy singleton infant with a birth weight of at least 2500 grams, and
- agree to participate and sign an informed consent; if underage (12-17 years), a legal representative will also have to agree to sign the informed consent
Who cannot join
- Plans to move permanently outside study area
- Has a medical, intellectual or psychological disability
- Contraindication for breastfeeding
- Children born with < 2500 grams
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Côte d’Ivoire1 site
Taabo Health and Demographic Surveillance
Taabo
Siaka Koné, +225 0749069627, Siaka.kone@csrs.ci
About this study
Official title: Taabo Enhanced Nutrition and Development Through Economic Rewards
The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are:
- Does the social transfer increase complementary breastfeeding rates at 24-months postpartum?
- Does the social transfer increase complementary breastfeeding duration?
- Does the social transfer impact child health and development?
- Does the social transfer impact maternal physical and mental health?
Read more
Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding.
Participants will:
Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire
- Conditions
- Breastfeeding, Breastfeeding Education, Breastfeeding Duration, Breastfeeding Continuation, Child Growth, Stress
- Being tested
- Social Transfer
- Keywords
- breastfeeding, cash transfer, child health, maternal health, mental health, child growth, child development, education
- Medical subject headings
- Breast Feeding, Communicable Diseases, Anemia, Weight Loss, Psychological Well-Being, Diarrhea, Cough, Eczema
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Social TransferOther
A social transfer will be given conditioned upon breastfeeding at 24-months postpartum.
| Study group | Role | What they receive |
|---|---|---|
| Social Transfer | Experimental | A social transfer is provided at the 24-month visit, conditional on the mother still breastfeeding at the time of the visit. They also receive education about current breastfeeding recommendations. Receives: Other: Social Transfer |
| Control | No intervention | No intervention is provided besides education on current breastfeeding recommendations. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of Complementary Breastfeeding
Prevalence of complementary breastfeeding at 24 months postpartum.
Measured: from 12 to 24 months postpartum
Complementary Breastfeeding Duration
Duration of complementary breastfeeding in weeks.
Measured: from 12 to 24 months postpartum
Secondary outcomes (16)
Weight-for-Age z-score
Infants will be weighed in kilograms by a mobile weighing scale. Measurements will be analyzed as age standardized z-scores.
Measured: 12 months; 24 months
Child Health Outcomes
We will assess the child's health outcomes by using a questionnaire administered to the caregiver. The questionnaire will ask a range of yes or no questions about child diarrhea, respiratory illness, fever, and child antibiotic use.
Measured: 12 months; 24 months
Percent weight loss
Percent weight loss will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Percent weight loss will be calculated as ((current weight - pregnancy weight) / pregnancy weight) × 100.
Measured: 12 months; 24 months;
Mother and Child Hemoglobin Levels
We will assess the mother and child anemia levels. The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Iron levels will be analyzed as a continuous outcome.
Measured: 12 months; 24 months
Maternal Depression
Maternal postpartum depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9); categorized as a binary: no depression (score <10) or depression present (score ≥10).
Measured: 12 months; 24 months
Height-for-age z-score
Height will be measured in centimeters by using a Height Measuring Device, stadiometer, 20-205cm. All measurements will be analyzed as age standardized z-scores
Measured: 12 months; 24 months
Mid-upper arm circumference (MUAC)
Infants will be measured for mid-upper arm circumference (MUAC) using non-stretchable measuring tape. All measurements will be analyzed as age standardized z-scores.
Measured: 12 months; 24 months
Mother and Child Anemia
The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Hemoglobin levels (gm/dL) will be used to categorize mothers and children into a binary variable: anemic or not anemic.
Measured: 12 months; 24 months
Maternal weight change
Weight weight change will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Maternal weight change will be calculated as the difference between postpartum weight and pregnancy weight. Because pregnancy weight varies by gestational age, analyses will control for gestational age at pregnancy weight measurement and time postpartum at outcome measurement.
Categorized as: no weight loss (0 kg); moderate weight loss (<0 to >-5 kg); high weight loss (≥-5 kg); moderate weight gain (>0 to <5 kg); high weight gain (≥5 kg).
Measured: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be categorized as low, normal, or high according to standard clinical thresholds.
Measured: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be analyzed as a continuous measure.
Measured: 12 months; 24 months;
Caregiver Reported Early Development Instruments (CREDI) cognitive z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
CREDI language z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
CREDI motor z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
CREDI social-emotional z-score
The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure.
Measured: 12 months; 24 months
Maternal Anxiety
Maternal postpartum anziety will be assessed using the the GAD-7 (Generalized Anxiety Disorder-7); a seven-item self-report questionnaire designed to measure the severity of anxiety; categorized as: Minimal Anxiety: score 0-4; Mild Anxiety: score 5-9; Moderate Anxiety: score 10-14; Severe Anxiety: score 15-21
Measured: 12 months; 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2026
- Study start1 Jun 2026 (estimated)
- Primary completion28 Feb 2028 (estimated)
- Study completion28 Feb 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BreastfeedingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1,040 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Swiss Tropical & Public Health Institute
- Sponsor type
- University, hospital or other
- Collaborators
- Centre Suisse de Recherches Scientifique en Côte d'Ivoire
- Responsible party
- Principal investigator, Jordyn Wallenborn, Swiss Tropical & Public Health Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07569172
- Sponsor's protocol ID
- 2025-50
- Acronym
- TENDER
- Status last verified
- Apr 2026
- First submitted
- 15 Apr 2026
- Last updated
- 6 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Taabo Enhanced Nutrition and Development Through Economic Rewards
- ClinicalTrials.gov ID
- NCT07569172
- Acronym / sponsor ID
- TENDER / 2025-50
- Conditions
- Breastfeeding, Breastfeeding Education, Breastfeeding Duration, Breastfeeding Continuation, Child Growth, Stress
- Keywords
- breastfeeding, cash transfer, child health, maternal health, mental health, child growth, child development, education
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 1,040 participants (estimated)
- Lead sponsor
- Swiss Tropical & Public Health InstituteUniversity, hospital or other
- Collaborators
- Centre Suisse de Recherches Scientifique en Côte d'Ivoire
- Study start
- 1 Jun 2026 (estimated)
- Primary completion
- 28 Feb 2028 (estimated)
- Study completion
- 28 Feb 2028 (estimated)
- First posted
- 6 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are:
- Does the social transfer increase complementary breastfeeding rates at 24-months postpartum?
- Does the social transfer increase complementary breastfeeding duration?
- Does the social transfer impact child health and development?
- Does the social transfer impact maternal physical and mental health?
Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding.
Participants will:
Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Social Transfer | Experimental | Other: Social TransferA social transfer is provided at the 24-month visit, conditional on the mother still breastfeeding at the time of the visit. They also receive education about current breastfeeding recommendations. |
| Control | No intervention | –No intervention is provided besides education on current breastfeeding recommendations. |
Who may qualify
- Ages
- 12 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (8 listed)
- Are enrolled in the Taabo multigenerational birth cohort (MGC)
- Completed the postpartum interview of the Taabo MGC
- Have a child who is within two weeks of their 12-month birthday,
- are breastfeeding at time of recruitment,
- live in the Taabo HDSS, Côte d'Ivoire
Key exclusion criteria (4 listed)
- Plans to move permanently outside study area
- Has a medical, intellectual or psychological disability
- Contraindication for breastfeeding
- Children born with < 2500 grams
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Social TransferA social transfer will be given conditioned upon breastfeeding at 24-months postpartum. | Other | Social Transfer |
Primary outcome
Prevalence of Complementary Breastfeeding
Time frame: from 12 to 24 months postpartum
Prevalence of complementary breastfeeding at 24 months postpartum.
Complementary Breastfeeding Duration
Time frame: from 12 to 24 months postpartum
Duration of complementary breastfeeding in weeks.
16 secondary outcomes
Weight-for-Age z-score
Time frame: 12 months; 24 months
Child Health Outcomes
Time frame: 12 months; 24 months
Percent weight loss
Time frame: 12 months; 24 months;
Mother and Child Hemoglobin Levels
Time frame: 12 months; 24 months
Maternal Depression
Time frame: 12 months; 24 months
Height-for-age z-score
Time frame: 12 months; 24 months
Mid-upper arm circumference (MUAC)
Time frame: 12 months; 24 months
Mother and Child Anemia
Time frame: 12 months; 24 months
Maternal weight change
Time frame: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Time frame: 12 months; 24 months;
Change in systolic and diastolic blood pressure (mmHg)
Time frame: 12 months; 24 months;
Caregiver Reported Early Development Instruments (CREDI) cognitive z-score
Time frame: 12 months; 24 months
CREDI language z-score
Time frame: 12 months; 24 months
CREDI motor z-score
Time frame: 12 months; 24 months
CREDI social-emotional z-score
Time frame: 12 months; 24 months
Maternal Anxiety
Time frame: 12 months; 24 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2026.
- Individual participant dataSharing planned: Yes
Related trials for Breastfeeding
Active, not recruiting
Effect of Exercise Training on Breastmilk Composition
Obesity
RecruitingObservational study
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Pregnancy Related
RecruitingObservational study
Experiences of Mothers Considering Breastfeeding Cessation: Decision-Making, Method Exploration, and Support Needs
Breastfeeding Cessation
Recruiting
Methyl Donor-Rich Diet in the Postpartum Period
Postpartum Depression (PPD), Breastfeeding
Not yet recruiting
Postpartum Care in the NICU Multi-Site Breastfeeding
Postpartum Complication, Postpartum
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Social Transfer in people with Breastfeeding and Breastfeeding Education, run by Swiss Tropical & Public Health Institute at 1 site in Côte d’Ivoire.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Côte d’Ivoire. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of Complementary Breastfeeding (time frame: from 12 to 24 months postpartum). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.